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Abstract
Background: Parkinson's disease is a progressive neurological disorder resulting from a
degeneration of dopamine producing cells in the substantia nigra. Clinical symptoms typically affect
gait pattern and motor performance. Evidence suggests that the use of individual auditory cueing
devices may be used effectively for the management of gait and freezing in people with Parkinson's
disease. The primary aim of the randomised controlled trial is to evaluate the effect of an individual
auditory cueing device on freezing and gait speed in people with Parkinson's disease.
Methods: A prospective multi-centre randomised cross over design trial will be conducted. Forty-
seven subjects will be randomised into either Group A or Group B, each with a control and
intervention phase. Baseline measurements will be recorded using the Freezing of Gait
Questionnaire as the primary outcome measure and 3 secondary outcome measures, the 10 m
Walk Test, Timed "Up & Go" Test and the Modified Falls Efficacy Scale. Assessments are taken 3-
times over a 3-week period. A follow-up assessment will be completed after three months. A
secondary aim of the study is to evaluate the impact of such a device on the quality of life of people
with Parkinson's disease using a qualitative methodology.
Conclusion: The Apple iPod-Shuffle™ and similar devices provide a cost effective and an
innovative platform for integration of individual auditory cueing devices into clinical, social and
home environments and are shown to have immediate effect on gait, with improvements in walking
speed, stride length and freezing. It is evident that individual auditory cueing devices are of benefit
to people with Parkinson's disease and the aim of this randomised controlled trial is to maximise
the benefits by allowing the individual to use devices in both a clinical and social setting, with
minimal disruption to their daily routine.
Trial registration: The protocol for this study is registered with the US NIH Clinical Trials
Registry (NCT00727467).
Background
Parkinson's disease (PD) is a progressive neurological dis-
order resulting from a degeneration of dopamine produc-
ing cells in the substantia nigra [1]. Clinical symptoms
such as tremor, rigidity, bradykinesia, hypokinesia and
postural instability classically affect gait pattern and
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with PD have an inability to maintain internal gait
rhythm [4], resulting in an abnormal gait pattern includ-
ing short shuffling steps, decreased arm-swing [5], freez-
ing [4-6], festination [7], decreased stride length [8,9],
reduced walking speed and increased cadence and double
stance time [2,4].
Rubenstein and colleagues [10] advocate the use of cueing
devices in physiotherapy, as such devices have demon-
strated an immediate effect on gait, with improvements in
walking speed, stride length and cadence [8,9]. Cueing is
defined as using external temporal or spatial stimuli to
facilitate movement, gait initiation and continuation [6],
and may be used effectively in a home environment for
the management of gait and freezing in individuals with
PD [11]. The RESCUE trial [11] demonstrated the efficacy
of the use of individual auditory cueing devices (IACD).
However, the technology used in this protocol is not com-
mercially available to date. Therefore, in this article we
describe a protocol to evaluate the effect of a widely avail-
able IACD – the Apple iPod-shuffle™ (iPod) on freezing
and gait speed.
The iPod is an off-the-shelf, low cost MP3 player, combin-
ing the latest auditory technology with an aesthetically
appealing, built-in clip design and user-friendly interface.
The iPod can be attached to any item of clothing without
being conspicuous and the in-ear headphones have excel-
lent sound quality and fit comfortably and securely in the
ear.
It is not exactly clear how AC improves gait, however
McIntosh and colleagues [12] hypothesise that an external
AC compensates for the defective internal rhythm of the
basal ganglia. Research also suggests that AC may provide
a rhythmic training mechanism because the effects of AC
on the individual remained even after cues were removed
[11-14]. In the study by McIntosh and colleagues [12],
people with PD who listened to music with an overlaid
AC whilst exercising showed lasting gait improvements,
compared to those who exercised without an AC. In a sim-
ilar study [14], individuals with PD who listened to music
with an AC on a daily basis for a month without gait train-
ing showed significant improvements in gait velocity and
step length.
Background Work
A systematic review of randomised control trials (RCTs)
was explored [15]. The review demonstrated that signifi-
cant improvements in walking speed, stride length and
cadence were evident in the 'experimental' groups when
AC was used as an intervention [16,17]. The primary gait
deficiency in people with PD has been described as an ina-
bility to generate sufficient amplitude of movement [18];
therefore cues should be aimed at increasing step ampli-
tude [18] and enlarging stride length to have a maximum
impact on normalising gait patterns of people with PD
[19].
The review [15] also suggested that by increasing the audi-
tory cueing (AC) frequency by +10% to 20% of individu-
als with PD natural step frequency, there is an immediate
effect on walking speed and stride length [19-21]. How-
ever, the effects of increased stride length have been
reported as inconsistent in people with PD who freeze
[22]. Preliminary findings on people with PD who freeze
indicate that lowering the AC frequency by 10% (-10%) of
the individuals self-selected walking speed can help to
improve their stride length [22,23]. Therefore the investi-
gators calculated and pre-loaded 100 baseline frequencies
(less 10%) in the sound of a metronome beat in an MP3
format (30 – 130 BPM) onto a DVD-R [24].
A user manual was created with a set of instructions that
gives each physiotherapist a step-by-step guide on how to
calculate the correct beat for their participants and how to
successfully upload this beat onto the iPod. In addition
physiotherapists in participating centres attended a train-
ing session on how to complete the tasks. A pack includ-
ing the DVD-R, user manual, information leaflet and
consent form was sent to participating centres. Recruit-
ment is due to commence in January 2009.
In addition, other authors have found that a single task
attention strategy such as walking in a straight line, with a
single auditory cue, resulted in significant normalisation
of gait parameters with improvements in walking speed,
step amplitude, and step frequency [20,23,25-30]. The
results of a recent study demonstrated a significant
increase of 0.7 m in mean step length with AC compared
to walking with no cues in a dual motor task, and signifi-
cant increases in step amplitude with rhythmic auditory
cueing during dual and multi-task performances in the
home [23].
Using this body of evidence, the investigators developed a
protocol to evaluate the impact of a low cost, widely avail-
able individual auditory cueing device on freezing and
gait speed in people with Parkinson's disease.
Aims and Objectives of the Study
The primary aim of the study is to evaluate the effect of an
IACD i.e. Apple iPod-shuffle™, on freezing and gait speed
in people with a diagnosis of PD through the implemen-
tation of a randomised controlled trial. A secondary aim
of the study is to evaluate the impact of such a device on
the quality of life of people with PD through the adminis-
tration of a self-report questionnaire. The IACD will be
pre-loaded with an individualised auditory cueing fre-
quency (metronome sound) matched to the walking
speed of the person.Page 2 of 6
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Study Design
A randomised cross over design will be used. Forty-seven
subjects will be randomised into either Group A or Group
B using sealed, computer generated random numbers.
Ethical Considerations
The study has obtained ethical approval from Trinity Col-
lege, University of Dublin Research Ethics Committee (3/
7/08).
Intervention
On Days 1–8 of the trial, the participants in Group A and
Group B will be given the iPod, loaded with podcasts.
During this period they will familiarise themselves with
the functionality of the device i.e. turning the device on
and off, increasing and decreasing the volume and insert-
ing the earphones into the ear. They will be instructed to
use the device only when sitting at home, and also
instructed that the device should not be turned on when
walking or performing any mobility related or daily tasks.
Investigators will schedule a phone call to check the
device is being used properly and that the participant is
not having any problems.
On Days 8–15, participants in Group A will be allocated
to the 'intervention' phase. Each participant will be given
an iPod containing an auditory cue in the form of a con-
tinuous metronome beat, individualised to the person's
walking frequency (less 10%). Participants will be
instructed to listen to the cueing when they are perform-
ing any mobility related tasks. They will be encouraged to
listen to the rhythmical cue and to try to match their heel
strike with the beat of the metronome sound on the
device. During this time period, participants in Group B
will be allocated to the 'control' phase. Participants will be
provided with the iPod shuffle containing no music or
metronome beat. Participants will be instructed to con-
tinue using the device in a similar manner to that of the
first week. On Days 15–23, participants in Group A will be
allocated to the 'control' phase and participants in Group
B will be allocated to the 'intervention' phase. The pro-
gression from screening and enrollment to randomisation
is illustrated in Figure legend 1.
Outcome Measures
Assessments will be taken 3 times over the 3-week period
on days 8, 15 and 23. A follow-up assessment will be com-
pleted after 3 months. The primary SOM in this study is
the Freezing of Gait Questionnaire (FOGQ) [31]. The
severity of freezing of gait is most accurately assessed by
the FOGQ. The questionnaire focuses solely on freezing
and does not include items relating to falling or festina-
tion. The FOGQ has been shown to be both valid and reli-
able as an outcome measure in people with PD [31].
Secondary outcomes will also be utilised including the
10MWT [32], TUG [33] and the MFES [34]. The 10MWT
[32] has been found to be valid and reliable in measuring
speed in people with PD and will be used as a measure of
gait speed during the different time-points in the study.
The TUG [33,35,36] has been used as a tool for measuring
basic mobility performance and has been proven to be
both valid and reliable in people with PD [35]. The MFES
[34], unlike the Falls Efficacy Scale (FES) [34,37], assesses
outdoor activities as well as indoor activities and demon-
strates greater internal test-retest reliability then the origi-
nal FES. The MFSE will be used to evaluate any change
which may occur in an individuals falling pattern due to
auditory cueing.
In addition, the impact of the AC device on the individual
and their quality of life with be explored using a semi-
structured interview. This interview will be conducted by
a person unknown to the participant. All interviews will
be audio-recorded.
Participant Selection
The potential participants involved in this study will be
volunteers recruited from the Parkinson's Association of
Ireland, as well as suitable medically stable candidates rec-
ommended by a consultant and/or physiotherapists from
a number of hospitals and day centres in Ireland.
Inclusion/Exclusion criteria
Individuals will be admitted to the study if they present
with a formal diagnosis of PD and are recommended for
participation to the study by a consultant and/or physio-
therapist. Participants on a stable medication regime who
freeze at least once a week (minimum score of 2 on item
3 of the FOGQ) and who freeze for at least 2 seconds
(minimum score of 1 on item 4 of FOGQ).
Participants will be excluded if they are attending physio-
therapy at the time of recruitment. Such participants may
demonstrate an improvement in gait pattern following
physiotherapy intervention, which may not be attributa-
ble to the AC device. Individuals who are unable to use
the IACD, who cannot hear the auditory cues and anyone
unwilling to provide written informed consent will be
excluded. Additionally individuals with acute co-morbid-
ities influencing mobility will also be excluded. Potential
participants with a cognitive impairment (< 24 MMSE) or
with long/unpredictable "off" periods making stable test-
ing difficult will also be excluded.
Recruitment
The nominated physiotherapist in each participating cen-
tre will be responsible for assessing eligibility for inclu-
sion into the study and also for obtaining informed
consent from the patient. Following identification of suit-Page 3 of 6
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Outline of RCT study designFigur 1
Outline of RCT study design.
5 Approved sites
Written informed consent
Excluded if no written consent given
Randomisation
Group A Group B 
Day 1: Induction to IACD Day 1: Induction to IACD 
Day 1-7: Familiarisation period in using 
the IACD
Day 1-7: Familiarisation period in using 
the IACD
Day 8: Baseline assessments of OM’s Day 8: Baseline assessments of OM’s
Day 8-15: Intervention phase. IACD with 
AC
Day 8-15: Control phase. IACD with no 
AC
Day 15: Reassessment of OM’s Day 15: Reassessment of OM’s
Day 15-23: Control phase. IACD with no 
AC
Day 15-23 Intervention phase. IACD with 
AC
Day 23: Reassessment of OM’s Day 23: Reassessment of OM’s
3-month follow-up assessments of OM’s 3-month follow-up assessments of OM’s
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role of the participant will be outlined and any questions
answered by the physiotherapist. The person with PD will
receive an information brochure in advance of being
asked to give written informed consent. Participants will
have seven days between receipt of the information bro-
chure and being requested to give written consent. Fol-
lowing the 7-day interval, the physiotherapist will answer
or clarify any further questions that arise and the partici-
pant will be requested to sign a consent form. If they are
unwilling to give written consent, they will be excluded
from the study. If they decide to partake in the study, par-
ticipants will be advised that they can withdraw from the
study at any time and it will not interfere with their rou-
tine rehabilitation programme. Participants will be allo-
cated a reference code. Names and other details that may
identify the participants will be removed.
Randomisation
To minimise the possibility of recruitment bias, a person
independent of the recruitment process will complete ran-
dom group allocation. Computer generated random
numbers will be kept in pre-sealed envelopes in a locked
drawer in the Department of Physiotherapy. Allocation
will be revealed after recruitment by a telephone call from
the physiotherapist to an independent person, who will
open the next envelope in the sequence and give the ran-
domisation information to the physiotherapist. Each
envelope will only be opened on enrolment of an eligible
participant. After allocation has been revealed, the appro-
priate intervention will be organised by the physiothera-
pists carrying out the study.
Power
Sample size is based on power analysis. A sample size cal-
culation was performed for the two quantitative meas-
ures, namely the TUG and 10MWT. Power calculations
indicate that a total of 47 participants are needed in order
to detect with 80% power a difference of 20% between the
groups at significance of level of 5%. It is anticipated that
it will take 6 months to recruit the required number of
participants.
Analysis
All data will be collected on paper and the records will be
stored by registration number in a secure cabinet. Ano-
nymised data will be transferred to a computer database
and secured using a password. An independent researcher
will cross check all entries. Appropriate statistical tests will
be carried out on the data using MINITAB Release 13.1.
The purpose of the statistical analysis is to test the hypoth-
esis that there will be a statistically significant difference in
freezing, gait speed and number of falls from baseline to
post-intervention assessment. Firstly, the participants'
demographic details and primary and secondary outcome
measure scores will be compared in the two groups at
baseline. If necessary, adjustments for baseline variables
will be made using analysis of covariance. Analyses will be
carried out to examine the difference between the groups
with respect to the change in the FOGQ score from base-
line to post-intervention assessment. Secondary outcomes
will be compared between the two groups using Student's
t-test or the Wilcoxon rank sum test for ordinal data.
Descriptive statistics will also be used to represent demo-
graphic data.
All interviews will be transcribed verbatim and examined
in terms of themes according to the method devised by
Miles and Hubberman [39]. Firstly, participants responses
to each question will be transferred into a Microsoft excel
document to facilitate analysis. Following analysis of the
responses to each question, a coding system will be devel-
oped in order to facilitate the identification of recurrent
responses. Three researchers will be provided with the
responses to all of the questions in an unencoded format;
thereafter they will independently code the responses
sequentially using the predefined codes. Any coding disa-
greements will be resolved through discussion.
Discussion
Auditory cueing as a physiotherapy intervention is not a
new concept; however, the technology to date has not
been practically and commercially viable for use in a clin-
ical setting. By lowering the cueing frequency by 10% of
the individuals self-selected walking speed, evidence sug-
gests that this may help to normalise Parkinsonian gait
patterns in people who freeze.
The iPod and similar devices provide a cost effective and
an innovative platform for integration of IACDs into the
clinical setting, social and home environments and are
shown to have immediate effect on gait, with improve-
ments in walking speed, stride length and cadence. It is
evident that IACDs are of benefit to people with PD and
the aim of this RCT is to maximise the benefits by allow-
ing the individual to use devices in both a clinical and
social setting, with minimal disruption to their daily rou-
tine.
Conclusion
The self-report questionnaires will allow researchers
deeper insight into the impact of IACDs on patients. By
establishing evidence based interventions such as
described in this protocol, can we strive to reduce the
impact of PD related motor symptoms on the individual.
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